SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1.51 |
| Enterprise Value ($M) | -1.27 |
| Book Value ($M) | -2.04 |
| Book Value / Share | -3.67 |
| Price / Book | -0.74 |
| NCAV ($M) | -2.16 |
| NCAV / Share | -3.87 |
| Price / NCAV | -0.70 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.62 |
| Return on Equity (ROE) | -2.05 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.61 |
| Current Ratio | 0.61 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.99 |
| Assets | 3.11 |
| Liabilities | 5.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | -32.39 | |
| 13G/A | Intracoastal Capital, Llc | 4.50 | -48.01 | |
| 13D/A | L.I.A. Pure Capital Ltd | 3.55 | 0.00 | |
| 13G/A | Geller Ehud | 19.85 | -89.48 | |
| 13G/A | XT Holdings Ltd. | 5.20 | -92.47 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 43,589 | 168,311 | 25.90 | |
| 40,392 | 231,582 | 17.44 | |
| 90,862 | 284,471 | 31.94 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PLUR – Pluri Inc. | PMCB – PharmaCyte Biotech, Inc. |
| PMN – ProMIS Neurosciences, Inc. | PROK – ProKidney Corp. |
| PRPH – ProPhase Labs, Inc. |
Financial data and stock pages provided by
Fintel.io